PharmaCyte Biotech Q1 EPS $(0.54) Up From $(1.23) YoY, Sales $0.00, Same YoY

Benzinga Newsdesk www.benzinga.com Negative 76.4%

Neg 76.4% Neu 0% Pos 0%

PharmaCyte Biotech (NASDAQ:PMCB) reported quarterly losses of $(0.54) per share. This is a 56.1 percent increase over losses of $(1.23) per share from the same period last year. The company reported $0.00 in sales this quarter. This is the same as the same period last year.